FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)

View source ↗

Summary

FDA approved a supplemental application for enalapril maleate from Oceanside Pharmaceuticals, indicating an updated/expanded labeling for this ACE inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Left Ventricular Dysfunction After Myocardial Infarction

Drugs mentioned

• Enalapril (enalapril)

Snippet

SUPPL AP for ENALAPRIL MALEATE (ENALAPRIL MALEATE)